Clinical trial
Duloxetine vs. Active Comparator for the Treatment of Depression
NCT00067912 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00067912 |
|---|---|
| Title | Duloxetine vs. Active Comparator for the Treatment of Depression |
| Official title | Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride, Venlafaxine Extended Release |
| Enrollment | 480 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2004 |
| First posted | Sep 3, 2003 |
| Last update posted | May 21, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: